Main > ONCOLOGY (**) > Lung>NSCLC>MET>METex14+ > TREAT.: > CH. N. Capmatinib Tablets

---

CH. N. Capmatinib Tablets's subsections
(*) EU Approval Date: 2022. 06.22
(*) JP Approval Date: 2020. 06.29.
(*) USA Approval Date: 2020. 05.06.
Company
Patent>EU Patent Numbers
Patent>JP Patent Number
Patent>USA Patent Numbers
RTM
RTM Web-Site

CH. N. Capmatinib Tablets's products
This section has no products